InvestorsHub Logo
icon url

Investor100

07/29/09 11:16 AM

#15335 RE: theparty #15334

Roth Capital Initiates Coverage on BioDelivery Sciences (BDSI) with a Buy

More News related to New Coverage
July 29, 2009 7:44 AM EDT

Roth Capital initiates coverage on BioDelivery Sciences (Nasdaq: BDSI) with a Buy. Price target $7.25.

To see more analyst ratings on BDSI Click Here.

BioDelivery Sciences International, Inc. operates as a specialty pharmaceutical company in the United States.

http://www.streetinsider.com/New+Coverage/Roth+Capital+Initiates+Coverage+on+BioDelivery+Sciences+(BDSI)+with+a+Buy/4826071.html

GLTA

Investor 100